← back to database
Pivotal bioVenture Partners invests in transformative therapeutics across North America and Europe, backing companies from creation and early development through later private rounds and the public markets.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$389 million Fund II
Latest fund vintage
2023
Investing team
AJ Velasquez-MaoSenior Associate
Brian MillsVice President
Peter BisgaardManaging Partner
Rob HopfnerManaging Partner
Tony HoSenior Science Partner
How to reach them
Notable investments
Sources
pivotallifesciences.com ↗pivotallifesciences.com/pivotal-bioventure-partners ↗pivotallifesciences.com/team ↗businesswire.com/news/home/20231218513778/en/Pivotal-Life-Sciences-Announces-the-Closing-of-%24389M-for-Pivotal-bioVenture-Partners-Fund-II ↗sec.gov/Archives/edgar/data/1693011/000119312523205268/d528287dsc13da.htm ↗